Friday, 27 February 2026

Children's Health Scotland Says: "The time for promises has passed - the time for action is now"

“We know what it feels like to wait too long for help, to feel invisible, and to fight for the care we need. Promises are not enough. Action is everything.” 

Young Health Rights Defender, speaking on the launch of Scotland’s new children’s health manifesto

Scotland is failing too many of its children. Long waits, inconsistent care, and overstretched systems mean thousands of young people are not receiving the support they need to stay healthy, safe and well. Scotland is now at a crucial moment for children’s health. 

Scotland’s new Manifesto for Every Child’s Right to Health has been developed by young people, for young people. Launched by leading children’s health rights charity Children’s Health Scotland, the manifesto places the voices, experiences and priorities of Young Health Rights Defenders at its core, making it one of the strongest youth‑led calls for change in children’s health in Scotland today. 

Guided directly by their lived experiences of long waits, inconsistent care and overstretched systems, the Young Health Rights Defenders have shaped the principles, priorities and demands set out in the manifesto.

Commenting on the Manifesto, Helen Forrest, Chief Executive of Children’s Health Scotland, told That's Health: “This manifesto belongs to the children and young people who helped create it. Our role has simply been to listen, support and amplify their voices. They are calling for urgent, meaningful action — and Scotland must respond.”

Grounded in national evidence and the truth of young people’s experiences, the Manifesto sets out clear, practical steps to ensure every child in Scotland receives the dignity, care and understanding they deserve.

The Manifesto call for FIVE key actions

The Manifesto asks leaders across Scotland to commit to:

Timely, equitable, rights‑based care that prevents crisis rather than responds to it.

Trauma‑informed services, especially for children facing poverty, adversity or disability.

Robust data and workforce planning to avoid future shortages and build sustainable capacity.

Meaningful participation of children, young people and families in shaping policy and practice.

Long‑term investment in third sector organisations providing essential, early and preventative support.

Healthcare is under pressure and children are feeling the impact

The manifesto presents a picture of services under significant strain:

Over 42,000 children were waiting for a neurodevelopmental assessment as of March 2025, with rises of more than 500% in some areas since 2020.

4,674 children and young people were on CAMHS waiting lists at the end of March 2025.

Nearly 49% of children waited more than 12 weeks to see a paediatrician.

81% of social care organisations reported recruitment challenges, making it harder to provide stable and consistent care.

Behind every statistic is a child who simply needs the right help at the right time. Long waits often increase the complexity of children’s needs, meaning they may require more intensive interventions later. This is happening against a backdrop of reduced paediatric workforce capacity, fewer staffed paediatric beds, and specialist mental health services struggling to keep pace with demand.

These pressures create a cycle that is difficult for families and services alike, but it is also a cycle that Scotland can break.

The Human Stories Behind the Statistics

Children’s experiences of health are never just medical they are emotional, social and practical too. Many children in Scotland are managing challenges that shape their daily lives:

189,000 children live with a chronic or long‑standing health condition.

240,000 children nearly 1 in 4 live in poverty, one of the strongest predictors of poor health, missed opportunities, and barriers to accessing care.

For many families, financial hardship and long-term conditions go hand-in-hand. Missed school, disrupted routines, increased caring responsibilities, and the stress of navigating complex systems all take a toll. There are 12,800 children in kinship families across Scotland, with over 66% in informal arrangements managing health needs without consistent support can feel particularly overwhelming.

Within this wider landscape, children’s oral health has become a clear marker of system pressures. Dental care is often a child’s most regular point of contact with health services, so when access breaks down, the effects ripple through daily life:

Over 80,000 children registered with NHS dentists have not seen one in five years.

Waiting times for treatment can stretch beyond a year.

Extractions under general anaesthetic remain the most common elective reason for hospital admission among children.

These issues are most severe in areas of highest deprivation, reinforcing the connection between poverty, delayed care, and poorer health outcomes. Oral health is not separate from children’s wellbeing — it is part of the same pattern of unmet need affecting their comfort, confidence and learning.

As one 13‑year‑old Health Rights Defender said: “Sometimes it feels like you have to wait until things get really bad before anyone helps you. That’s not fair.”

Young people told us repeatedly that delays affect their friendships, school life and sense of belonging. They want services that feel joined‑up, compassionate and centred around their rights.

Care‑Experienced Children Face Deep and Persistent Inequalities

The manifesto also highlights the challenges facing children in kinship, foster or residential care: 72% of children in care have Additional Support Needs more than double the general population. They are twice as likely to have developmental concerns and more likely to require early, trauma‑informed support.

Yet too often, their needs are addressed only at crisis points. As one young person shared: “Sometimes there’s no one who really understands what’s going on with you, you just get passed around.”

A Moment for Leadership an Opportunity for Change

As Scotland marks the 20th year of GIRFEC, this is a moment not just to revisit its principles, but to fulfil its promise. GIRFEC was designed to ensure every child grows up loved, safe and respected and to give them every opportunity to realise their potential. That should be our expectation, not our aspiration.

Early support doesn’t just transform childhoods — it leads to healthier adulthoods, stronger families and more resilient communities. Acting now helps children thrive today and strengthens Scotland’s future.

As Michelle Wilson, Head of Children’s Services for Children’s Health Scotland, explains: “Every day a child waits, they lose more than time. They lose opportunities, confidence, and sometimes hope. But we also know that when children get the right support early, when services join up, listen and respond, their lives can change incredibly quickly. Scotland has the talent, the compassion and the commitment to make that happen. 

If we start acting now, we can build a system that not only treats illness but truly nurtures every child’s potential. 

Article 24 of the UNCRC sets out every child’s right to the highest attainable standard of health and with the right focus and investment, Scotland can turn that right into something every child genuinely experiences.

"That’s the Scotland our children deserve, and it’s within reach.”

The Health Rights Defenders are ready to meet with policymakers, sector leaders and national bodies to ensure children’s voices guide Scotland’s decisions.

The full manifesto is available at:

https://www.childrenshealthscotland.org/every-childs-right-to-health-chs-launches-manifesto-for-change

Physical copies can also be requested.

Thursday, 26 February 2026

20 Yrs and 10,000 bikes for Children with Cancer. BBC “The One Show” Honours Charity Founder with One Big Thank you.

Last Thursday (19th Feb), The BBC One Show, along with some help from celebrities such as Alexander Armstrong and Sir Chris Hoy himself, pulled off a surprise “One Big Thank-you” for Mike Grisenthwaite, founder of the Nationwide Children’s Cancer Charity Cyclists Fighting Cancer.

Launched from his kitchen table 20yrs ago, CFC has grown hugely, and today has 4 Charity Bike shops in Cheltenham, London, Manchester and their HQ in Stratford-upon-Avon. 

The shops take donated bikes and parts as well as selling new accessories and servicing all types of bikes.

All proceeds from the shops and other fundraisers go towards providing more bikes and specially adapted trikes for children living with and beyond cancer in the UK. These bikes help them get outside and active, and have huge benefits for both their physical and mental wellbeing.

Since starting, the team at CFC have gifted over 10,000 bikes and trikes to children all over the country, as well as delivering exercise equipment to many Children’s Hospitals to introduce children to exercise during lengthy hospital stays.

All of this after Mike was inspired to “give back” having used exercise, and specifically Cycling, to get through his own arduous cancer treatment.

During the amazing piece which can be found on BBC iPlayer here (from 14:50min) https://www.bbc.co.uk/iplayer/episode/m002rkcm/the-one-show-19022026

Mike was fooled into thinking Alexander needed a puncture repair, before revealing the surprise. He then received heart felt messages from children and families his charity has helped as well as recognition of his huge achievements from Sir Chris Hoy, Family, Friends and Colleagues.

An emotional Mike had a rare speechless moment and was “blown away” by the recognition.

For more info on the charity and their activities go to www.cyclistsfc.org.uk

Polar Explorer Craig Mathieson Awarded Prestigious Polar Medal – Exclusive Interview Reveals Impact of His Youth Charity

Craig Mathieson & Neil Jurd in conversation
Scottish polar explorer and founder of The Polar Academy, Craig Mathieson, has been honoured with the Polar Medal in the King's New Year's Honours List 2026, recognising his outstanding contributions to polar exploration and youth development.

The medal, one of the UK's highest awards for polar service, celebrates Mathieson's decades of expeditions, including man-hauling to the South Pole in 2004, reaching the Geographical North Pole in 2006, and leading sea-kayaking missions along Greenland's east coast, alongside his groundbreaking work with The Polar Academy, the charity he established in 2013.

The Academy selects and trains overlooked young people (aged 13-17) facing trauma or invisibility in education, taking them on rigorous Arctic expeditions to Greenland. 

Through physical challenges, trust-building, and 24/7 support, it unlocks confidence, resilience, and aspiration, transforming participants into teachers, scientists, Royal Marines, and community leaders. 

Over 270 young people have taken part, with many now mentoring others and raising awareness.

In an exclusive video interview released on 29 December 2025, leadership coach and former British Army officer Neil Jurd OBE speaks with Mathieson about the Academy's origins, selection process, and why it succeeds where traditional systems often fail. 

Mathieson shares how compassion, belief in human potential, and deliberate challenges in extreme conditions build lasting change—drawing parallels to his own military and mountaineering background.

Watch the full interview here:  https://leader-connect.co.uk/videos/interview-with-craig-mathieson-of-the-polar-academy

"Seeing these kids step into their potential—despite everything—is the real purpose of the expedition," Mathieson says in the discussion.

Mathieson, also 'Explorer-in-Residence' at the Royal Scottish Geographical Society and recipient of an Honorary Doctorate from Abertay University, continues to lead the charity alongside his family team.

thepolaracademy.org

https://leader-connect.co.uk

World Teen Mental Wellness Day: Listening, Supporting, Acting

World Teen Mental Wellness Day shines a much-needed light on the emotional and psychological wellbeing of young people. 

The teenage years are a period of rapid change, socially, physically and academically, and while they can be exciting, they can also feel overwhelming.

In the UK, conversations around youth mental health have become more open in recent years, yet many teenagers still struggle in silence. 

A dedicated awareness day provides a chance to pause, listen and take meaningful action.

Why Teen Mental Wellness Matters

Adolescence is when identity, confidence and coping skills are being formed. Pressures can come from many directions:

Academic expectations

Social media comparison

Friendship dynamics

Body image concerns

Family challenges

Uncertainty about the future

According to NHS guidance, anxiety, low mood and emotional distress are increasingly common among young people. Early support makes a significant difference. 

When teens are equipped with healthy coping tools and trusted adults to talk to, long-term outcomes improve dramatically.

The Hidden Pressures of Modern Teen Life

Today’s teenagers navigate a digital landscape that previous generations did not. Social platforms can provide connection and creativity, but they can also amplify comparison and unrealistic expectations.

Organisations such as YoungMinds regularly highlight how exam stress, online bullying and social pressures can affect confidence and self-esteem.

For many teens, the challenge is not just dealing with stress, it’s knowing that what they are feeling is valid and that help is available.

Signs a Teen Might Be Struggling

Every young person is different, but some common indicators include:

Withdrawal from friends or activities

Changes in sleep or appetite

Irritability or sudden mood shifts

Drop in school performance

Loss of interest in hobbies

Talking negatively about themselves

None of these automatically signal a serious condition, but they do suggest a need for gentle conversation and support.

Practical Ways to Support Teen Mental Wellness

World Teen Mental Wellness Day is not only about awareness, it’s about action. Here are meaningful steps parents, carers and communities can take:

1. Create Safe Conversations

Ask open questions. Listen without judgement. Avoid rushing to solutions.

2. Encourage Healthy Routines

Regular sleep, balanced meals, physical activity and time outdoors support emotional resilience.

3. Limit Digital Overload

Encourage breaks from screens and promote positive online habits.

4. Promote Emotional Literacy

Help teens name and understand their feelings. Journalling and creative expression can help.

5. Seek Professional Support When Needed

If concerns persist, speak to a GP or access school counselling services. Early intervention is key.

Resources for UK Teens and Families

Support is available. Trusted organisations include:

YoungMinds – advice and a parents’ helpline https://www.youngminds.org.uk

Childline – confidential support for under 19s https://www.childline.org.uk

Samaritans – 24/7 emotional support https://www.samaritans.org

No young person should feel they have to cope alone.

A Community Responsibility

Teen mental wellness is not solely a family issue, it is a community one. Schools, youth groups, sports clubs and online spaces all play a role in shaping a teenager’s sense of belonging and self-worth.

World Teen Mental Wellness Day reminds us that checking in, listening properly and modelling healthy emotional behaviour can change a young person’s life trajectory.

A simple question  “How are you really feeling?” can open a door that might otherwise stay closed.

If you are marking the day, consider starting a conversation, sharing trusted resources or simply making time to listen. Small actions, consistently applied, create lasting impact.

World Music Therapy Day: The Healing Power of Sound

Every year, World Music Therapy Day shines a spotlight on something many of us instinctively understand: music changes how we feel. 

A single song can lift our mood, unlock a memory, calm anxiety, or help us process emotion. 

But music therapy goes far beyond simply listening to a favourite playlist. 

It is a structured, evidence-based clinical practice delivered by trained professionals.

In the UK, music therapy is provided by qualified practitioners registered with the Health and Care Professions Council and supported by organisations such as British Association for Music Therapy and NHS services.

So what exactly is music therapy... and why does it matter?

What Is Music Therapy?

Music therapy is a therapeutic approach that uses music intentionally to support mental, emotional, physical and social wellbeing. Sessions may involve:

Playing instruments

Singing

Songwriting

Listening and discussing music

Improvisation

Movement to music

No musical ability is required. The focus is not performance or talent. It is about expression, communication and connection.

A trained music therapist tailors sessions to the individual’s needs, whether that involves trauma recovery, neurological rehabilitation, dementia care, or support for children with additional needs.

The Health Benefits

1. Supporting Mental Health

Music therapy is widely used for anxiety, depression and trauma. Structured sessions can help people regulate emotions, reduce stress hormones and develop coping strategies.

For individuals who struggle to verbalise feelings, music provides a safe alternative language.

2. Dementia and Memory

Music has a powerful link to memory. Familiar songs can help people living with dementia reconnect with personal history and identity. Even when verbal communication declines, musical memory often remains intact.

3. Neurological Rehabilitation

Following stroke or brain injury, rhythm and melody can support speech recovery and motor function. Techniques such as rhythmic auditory stimulation help improve coordination and movement.

4. Children and Young People

Music therapy can support children with autism, ADHD or communication difficulties. It helps build confidence, social interaction and emotional awareness.

5. Pain and Stress Reduction

Listening to calming music can lower heart rate, reduce blood pressure and ease perception of pain. Hospitals increasingly integrate music therapy into palliative and cancer care settings.

Music Therapy vs. Listening to Music

It is important to distinguish between therapeutic music use and clinical music therapy.

Listening to music at home can certainly improve mood and relaxation.

Music therapy, however, involves structured goals, assessment and professional guidance.

Both have value – but clinical music therapy is a recognised healthcare intervention.

How You Can Mark World Music Therapy Day

You do not need to book a session to honour the day (though exploring local services is a worthwhile step). Here are simple, health-focused ways to participate:

Create a “wellbeing playlist” that lifts your mood

Spend 10 minutes listening to instrumental music mindfully

Try gentle drumming or rhythmic tapping as a stress release

Sing along to songs linked to positive memories

Explore local music therapy services in your area

The Science Behind the Sound

Research continues to show measurable benefits. Brain imaging studies reveal that music activates multiple regions at once – emotional centres, motor areas, memory circuits and even reward pathways.

Music increases dopamine (associated with pleasure and motivation) and can reduce cortisol (the stress hormone). It literally changes brain chemistry.

That is not mystical. It is neurological.

In a world that often feels noisy and overwhelming, music therapy reminds us that sound can also soothe, connect and heal.

Whether it is a choir in a community hall, a quiet piano session in a hospital ward, or a one-to-one therapeutic space, music remains one of the most accessible and powerful tools for wellbeing.

On World Music Therapy Day, take a moment to notice what music does for you. It may be doing more than you realise.

British Association of Musical Theraphy https://www.bamt.org/music-therapy/what-is-music-therapy

British Liver Trust launches campaign to tackle late diagnosis of rare liver conditions

The British Liver Trust has launched a new campaign ahead of Rare Disease Day to tackle the late diagnosis of rare liver conditions, after new analysis of patient survey data revealed that many people experienced symptoms before diagnosis. 

Yet around a quarter of symptomatic patients had their concerns dismissed or were sent home without further investigation.

Liver disease is often associated with alcohol or lifestyle factors. But many rare liver conditions are autoimmune or genetic, affecting people of all ages, including babies, children and young adults. 

This misconception can contribute to delays in diagnosis and prevent people from seeking timely support.

Analysis of responses from more than 1,000 people living with rare liver conditions across the UK found that around one in five patients who experienced symptoms were diagnosed “very late”, when their disease had already progressed and treatment options were limited.

In response, the British Liver Trust has launched No One Left Behind, a new campaign aimed at shining a spotlight on rarer liver conditions that are too often under-recognised and misunderstood.

The campaign calls for greater awareness of early warning signs among healthcare professionals and the public, improved information and support at diagnosis, and greater investment in research.

Persistent itching, nausea, abdominal pain and jaundice were among the most commonly reported early warning signs across rarer liver conditions, including Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC). These are chronic, progressive diseases that often require lifelong specialist care. In some cases, delayed diagnosis can lead to cirrhosis, liver failure or the need for transplantation.

According to the British Liver Trust, tens of thousands of people in the UK are living with rare liver diseases, many of which can take years to diagnose due to a lack of awareness and limited research.

Emma was diagnosed with autoimmune hepatitis more than two decades ago, aged just 17, after developing severe itching and jaundice and spending weeks in hospital undergoing tests. At the time, she had never heard of the condition and did not recognise that her symptoms were signs of serious liver disease.

Emma told That's Health: “So many people don’t realise liver disease doesn’t just affect people who drink alcohol. Conditions like mine are called ‘rare’, but they affect thousands of people.”

Rare Disease Day is marked globally each year on 28 February and aims to raise awareness of rare diseases and improve access to diagnosis, treatment and care for those affected.

Pamela Healy OBE, Chief Executive of the British Liver Trust, added: “Rare liver diseases may be less common, but for the thousands of people affected across the UK, their impact is life-changing. Too often, a lack of awareness leads to delayed diagnosis and unequal access to specialist care. 

"We need greater understanding, earlier diagnosis and sustained investment in research to ensure no one living with a rare liver condition is left behind.”

The British Liver Trust is the UK’s leading liver health charity and provides information, support and advocacy for everyone affected by liver disease. This includes people living with rare liver conditions such as autoimmune hepatitis, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), Alagille syndrome and biliary atresia.

For more information, visit www.britishlivertrust.org.uk.

Wednesday, 25 February 2026

Extreme cold increases risk of cardiac arrest by almost 20%, new study finds

Temperatures below -9°C increase the risk of cardiac arrest by 18.9% for over two weeks, new research from Corvinus University of Budapest has revealed.

Alongside Semmelweis University, Budapest University of Technology and Economics, the University of Pannonia, and the National Ambulance Service, researchers analysed temperature data with over 116,000 out-of-hospital cardiac arrest cases over a five-year period.

The lowest risk for cardiac arrest was observed at 19°C, with the number of cases increasing as the temperature grew hotter or colder. 

While there was notable risk above 27°C, the largest rise in risk was linked to cold spells (-9°C and below) lasting at least two days. This impact did not differ between men and women.

The researchers also identified an important difference in how heat and cold affect the body. Heat acts quickly and only up to a week, while cold spells place a longer-term strain on the body, with effects appearing after three days and increasing the risk of cardiac arrest for over two weeks after the cold period has ended.

“Although the effect of the weather is weak, it affects us all. In recent decades, climate change has made our weather more variable, and our bodies must adapt to this. This is particularly challenging for those who are unwell. While we have learned to pay attention to heatwaves, research shows that we must also consider the effects of cold weather,” Brigitta SzilĂ¡gyi, Associate Professor at Corvinus University and co-author told That's Health.

The researchers offer practical implications; during heatwaves, healthcare services need to respond rapidly, while cold periods require heightened readiness over longer periods. 

By incorporating these findings into regional warning systems, healthcare practices could also provide greater support, emphasising hydration during heat, and blood pressure management and appropriate clothing during cold periods.

These findings were first published in the journal Resuscitation Plus. The full paper is open access here 

https://www.sciencedirect.com/science/article/pii/S2666520425003315?via%3Dihub

Local housing charity raises £20,000 for Cornwall Blood Bikes

Colleagues at Coastline Housing have presented £20,000 to Cornwall Blood Bikes to help the local charity in its lifesaving work.

The money is the result of a year’s worth of fundraising by colleagues at the Cornish housing charity and this year they raised a record amount.

CEO Allister Young, who was proud to help hand over the cheque, told That's Health: “Coastline colleagues clearly felt very passionately about Cornwall Blood Bikes to raise such a fantastic amount. 

"Any of us living in or visiting Cornwall never know when we might need the services of this fantastic charity and its hard-working volunteers so we’ve been proud to fundraise for them across the past 12 months.”

Colleagues at Coastline raised the funds thanks to a number of events including their big annual marathon challenge in September where colleagues between them clocked up just over 3,000 miles in one day and raised £5,128. 

Participants walked, ran and cycled the miles, and one small group of colleagues even did a special motorbike ride to add some miles to the total, in tribute to Cornwall Blood Bikes and the many miles volunteers cover each year.

Across the year, staff at Coastline also held events such as BBQs, a quiz night, raffle, big breakfasts and a VE day celebration.

Cornwall Blood Bikes is a volunteer-run charity providing a free, "out of hours" courier service for the NHS, transporting blood, plasma, urgent samples, medication, and donor breast milk between hospitals, hospices, and care homes. They operate weekday nights (5pm–7am) and 24 hours on weekends/bank holidays to save the NHS money on courier fees.

Jayne Penlerick, Chair of Cornwall Blood Bikes, told us: “We're really just blown away by this £20,000 donation. We are all volunteers and Cornwall Blood Bikes gets busier each year. 

"Last year the team undertook around 7,800 jobs and rode a total of around 244,000 miles doing so. We also celebrated our 10th anniversary. 

"We really wouldn’t be able to do any of this without people like the team at Coastline Housing who fundraise so hard for us. It means so much to be able to use this money to keep these bikes on the road for the people of Cornwall.”

Assistant Director of Finance at Coastline Zoe Field, who organised the Coastline charity marathon challenge, added: “Every year I think to myself that we won’t beat our previous total in terms of miles and money – but then we seem to manage it. I’m so proud of the way colleagues get involved and really push themselves to make a difference and we know this money will make a real difference to Cornwall Blood Bikes.”

https://www.coastlinehousing.co.uk

https://cornwallbloodbikes.org

Gipsy Hill family’s fundraising in memory of kind-hearted 18 year old helps fund vital new leukaemia research

A Gipsy Hill, London, family’s fundraising in memory of their teenage daughter has helped fund a major new research project into children’s blood cancer.

Ruby Fuller, 18, died during the COVID 19 lockdown in May 2020, just under a year after she was diagnosed with a rare type of lymphoma. 

During that time, she spent over 200 nights in hospital and endured incredibly intensive treatments. However, they weren't enough to save her when the cancer transformed into leukaemia.

After Ruby died, her parents, Emma Jones and Dylan Fuller, were told how few treatment options exist for patients when T cell blood cancers relapse.

This prompted them to launch a Special Named Fund at CCLG: The Children & Young People’s Cancer Association called Ruby’s ‘Live Kindly, Live Loudly’ Fund to fundraise for research into childhood leukaemia and lymphoma.

Emma told That's Health: “Hearing there simply aren’t effective treatments yet made it very clear to us that if anything is going to change, it has to start with research.

“Setting up Ruby’s fund felt like a way to turn our heartbreak into something hopeful, something that could improve outcomes for other young people in the future.”

The fund has since raised over £290,000 and contributed to a new research project exploring better treatments for childhood leukaemia.

Emma feels the new project embodies Ruby’s motto of ‘live kindly, live loudly.’ She said: “This project is about kindness, developing safer, less brutal treatments, and it’s loud because it challenges the status quo and pushes for change where it’s badly needed.

“Supporting bold, innovative research like this feels exactly the kind of legacy Ruby would have wanted.”

The project, funded through a collaboration between CCLG and Children with Cancer UK, is led by Dr Maarten Hoogenkamp and Dr Vesna Stanulovic at the University of Birmingham.

Dr Stanulovic said: “We are making a new drug that will interfere with the metabolism of leukaemia cells – basically, it will kill cancer without affecting the rest of the body.”

The new drug aims to treat T cell blood cancer both at diagnosis and after relapse. While it's excellent at fighting leukaemia in the lab, the drug currently breaks apart too easily in the body. 

With this funding, the researchers hope to refine their drug to ensure it can survive long enough to effectively fight the cancer cells.

Dr Stanulovic added: “By only targeting the cancer cells with this treatment, we hope to prevent the huge toxicities that are normally seen in leukaemia treatment. 

"Our drug should be very friendly for patients and not require any further hospitalisation.”

Because of the expected lack of side effects, the researchers hope that their treatment could eventually be taken at home as a tablet.

Emma said that funding the project “means everything” to her family. And, despite Ruby’s ‘Live Kindly, Live Loudly’ Fund now having supported five research projects in total, she has no plans to stop fundraising.

This year’s plans include a London Tube Challenge, visiting all 272 tube stations in London as quickly as possible, and an auction to commemorate what would have been Ruby’s 25th birthday in October.

Vicki Brunt, Head of Fundraising at CCLG, said: “Ruby’s family and supporters have achieved an extraordinary amount in such a short time, and we are incredibly grateful for everything they’ve done.

“Their dedication is enabling vital work that could lead to kinder, more effective treatments for young people diagnosed with blood cancer.”

Gavin Maggs, Chief Executive of Children with Cancer UK, said: “Working together with CCLG allows us to achieve more for children and families affected by cancer.

“Between us, we can fund research that pushes boundaries and brings us closer to safer, more effective treatments, maximising impact and accelerating progress. Co-funding like this has to be the way forward, for our donors, for the academics, and most importantly, for the children.”

If you would like to donate a prize for the Ruby’s ‘Live Kindly, Live Loudly’ Fund auction, please contact emmacjones1000@gmail.com or, to support the fund, please visit specialnamedfunds.cclg.org.uk/rubys-live-kindly-live-loudly-fund

Dover mum’s fundraising helps launch major new childhood leukaemia research projects

A young Dover mum’s fundraising in memory of her 9-year-old son who died from leukaemia has helped leading cancer charities fund new research into the disease.

Josh Harber tragically died just two days after being diagnosed with acute myeloid leukaemia (AML) in 2019. 

Shockingly, Josh had been an apparently healthy, active child only days before his diagnosis and loved playing football. 

Since losing their son, Josh’s family have raised over £30k for research through Josh’s Gold Star Fund, a Special Named Fund at CCLG: The Children & Young People’s Cancer Association.

Josh’s mum Danielle, told That' Health: “Josh was football-mad and lived and breathed the game, but what everyone remembers most is his smile – so constant that he was lovingly nicknamed ‘Smiler.’ He could light up a room just by walking into it.

“More than anything, he was an amazing son and brother, and he is missed beyond words.

“Josh’s experience with AML changed our family forever. The speed and severity of his illness opened our eyes to how vulnerable children with cancer are, and how desperately more research, funding, and support are needed. We chose to fundraise in Josh’s name to honour his life and to help create a future where other families don’t have to endure the same heartbreak.”

Now, alongside other CCLG Special Named Fund families, Danielle’s fundraising has contributed to a £600,000 research-funding collaboration between CCLG and Blood Cancer UK, launching two pioneering research projects.

The projects, based at the University of Edinburgh and the University of Glasgow, aim to tackle some of the biggest challenges in childhood blood cancer, developing safer and more effective treatments for babies with leukaemia and children with acute myeloid leukaemia (AML).

The joint funding from Blood Cancer UK and CCLG will allow Dr Karen Keeshan at the University of Glasgow, to lead a project focused on AML, an aggressive blood cancer affecting around 100 children and young people in the UK each year. Dr Keeshan’s research will investigate a protein found on the surface of AML cells that is linked to more aggressive disease and treatment resistance but is not present on healthy blood stem cells.

Dr Keeshan told us: “For many children with AML, current treatments are simply not good enough. This project is about taking a clear biological signal we see in aggressive disease and testing whether we can turn it into a more precise, less toxic way of treating children whose cancer doesn’t respond well to standard therapies.”

Meanwhile, Dr Samanta Mariani at the University of Edinburgh aims to better understand why leukaemia in babies under one year of age is so difficult to treat. This is rare but extremely aggressive, and sadly only around half of babies diagnosed before their first birthday are successfully treated.

Dr Mariani will study a type of immune cell called a macrophage, which recent adult studies suggest can be ‘reprogrammed’ by leukaemia cells to help the cancer survive and resist treatment. These so-called leukaemia-associated macrophages have never before been studied in babies with leukaemia.

Dr Mariani said: “Leukaemia in babies behaves very differently to the disease we see in older children and adults, but we still know surprisingly little about what’s driving it.

“By studying how immune cells interact with leukaemia in babies for the first time, we hope to uncover biological mechanisms that could be exploited to make existing treatments work better and reduce harm for these very young patients.”

Ashley Ball-Gamble, Chief Executive of CCLG, said: “These projects have only been made possible thanks to the determination and fundraising of families who know first-hand the devastation caused by childhood cancer. Our Special Named Funds are driving forward research that could change outcomes for children in the future.”

Dr Richard Francis, Deputy Director of Research at Blood Cancer UK, added: “Thanks to decades of research, survival from the most common form of childhood leukaemia has been transformed - from just one in ten children surviving in the 1960s to around nine in ten today. 

"But for babies and children with aggressive forms of the disease, those gains have not been shared equally. 

"Every child like Josh deserves the best possible chance of survival, and that’s why funding innovative research like this in Scotland is so vital. It’s only possible because of the determination of families and supporters who refuse to accept that current treatments are good enough.”

Josh’s mum Danielle told us: “For our family, funding these two research projects means that Josh’s story didn’t end with his passing. His fund is helping move research forward, and knowing that his name is attached to work that could one day save other children’s lives brings us comfort and purpose.

“Our hope is that these research projects lead to better, kinder treatments for children with AML and other childhood cancers - treatments that give families more time, more options, and better outcomes. If this research can spare even one family the pain we’ve experienced, it will mean everything.”

https://www.cclg.org.uk

Tuesday, 24 February 2026

GrĂ¼nenthal licenses exclusive Australian rights to Qutenza® to Clinect

GrĂ¼nenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a topical, non-systemic, non-opioid patch indicated for the management of peripheral neuropathic pain. 

Under the agreement, Clinect will be responsible for obtaining marketing authorisation for Qutenza® in Australia and, upon approval, marketing and distributing the product in Australia.

"We firmly believe in the benefits that this non-opioid treatment option can provide to people suffering from peripheral neuropathic pain and continue to work on expanding its footprint to reach more patients worldwide," Jan Adams, Chief Commercial Officer (CCO) at GrĂ¼nenthal told That's Health.

"Clinect is an experienced specialist with a strong presence in Australia, and I look forward to joining forces with their team to bring our brand to Australia, a major market of the Asia-Pacific region."

"We value the opportunity to work alongside GrĂ¼nenthal, a global leader in pain management, to introduce Qutenza® to the Australian market,” said Merryn Wallace, General Manager at Clinect. “This agreement reflects our shared commitment to improving patient outcomes and aligns with Clinect’s strategy of partnering with companies who bring truly differentiated therapies to our region."

GrĂ¼nenthal acquired the global rights to Qutenza® in 2018 as part of its M&A-driven growth strategy. Since 2017, the company has invested more than €2.3 billion in successful M&A transactions, diversifying its portfolio, enhancing its profitability, and driving business growth. GrĂ¼nenthal continues to expand the footprint of the acquired brands and to create synergies throughout GrĂ¼nenthal's infrastructure, including manufacturing, supply, logistics, and commercial activities.

In Europe, Qutenza is indicated for the treatment of peripheral neuropathic pain in adults, either alone or in combination with other medicinal products for the treatment of pain. For further information, please visit www.grunenthalhealth.com.

www.grunenthal.com

That's Business: Mould Remediation Goes Digital: UKAME Launches Onl...

That's Business: Mould Remediation Goes Digital: UKAME Launches Onl...: As Awaab's Law forces landlords to act on damp and mould within days, UKAME launches the mould industry's first fully digital memb...

Medi-Globe Launches mAI Companion® World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe

Medi-Globe has today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS), addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.

Developed through a multi‑year collaboration with IHU Strasbourg, mAI Companion® has received MDR CE Mark certification, becoming the first‑of‑its‑kind AI assistant for pancreatic EUS approved for clinical use in Europe.

Addressing One of Medicine’s Toughest Imaging Challenges

Pancreatic cancer remains one of the deadliest malignancies worldwide, and early detection can significantly improve survival. EUS provides high‑resolution, close‑up imaging and allows targeted biopsy confirmation—but the technique demands years of experience, and subtle lesions can still be difficult to detect.

mAI Companion® functions as an intelligent “second set of eyes” during EUS, automatically analysing the head, body, and tail of the pancreas in real time to highlight solid and cystic lesions that may otherwise go unnoticed. 

The expected result: greater diagnostic confidence, more systematic exams, and fewer missed findings supporting earlier identification of pancreatic lesions including stages when treatment options and survival outcomes are significantly improved.

Built on Expert Knowledge — at Unprecedented Scale

AI performance depends on data quality. mAI Companion® was created in collaboration with leading European expert centres and trained on hundreds of real‑patient EUS videos containing more than five million expert‑annotated images. Each annotation was validated by experienced endoscopists, enabling the software to act like a trusted expert advisor beside the clinician.

First‑in‑Human Use, Clinical Evidence

mAI Companion® underwent first‑in‑human clinical use ahead of market introduction—a milestone Medi-Globe first reported in 2022. Patents covering key elements of the technology have been filed.

A tandem randomised EUS video trial involving 57 endoscopists—currently under peer‑review—demonstrated significantly higher diagnostic accuracy and a marked reduction in missed‑lesion rates when using AI compared with standard assessment.

Clear Clinical and Institutional Benefits

The MDR CE‑Marked mAI Companion® is expected to deliver practical value across all levels of clinical practice — improving confidence, consistency, and clinical quality in pancreatic EUS:

Experienced Endoscopists: Greater reassurance in complex or ambiguous cases with real‑time AI support by providing an extra set of eyes e.g. for small, hard‑to‑spot lesions .

Departments & Teams: Standardized EUS quality across operators, reduced variability, and faster development of junior staff.

Hospitals & Institutions: Stronger reputation, academic prestige and leadership in pancreatic cancer care.

Together, these benefits drive more confident exams, more consistent results, and better patient outcomes — reinforcing trust and institutional excellence in pancreatic EUS. Earlier and more reliable lesion detection supports faster diagnosis, earlier treatment decisions, and ultimately improved patient pathways in a disease where time is critical.

Expert Voices

“This product will revolutionize pancreatic care going forward – saving patients’ lives and making our job as physicians easier. Medi‑Globe moved faster to market than any similar effort I’ve seen, and deserves kudos for bringing the first in the world AI augmented EUS product to market. The collaboration with our R&D team and the preeminent Scientific advisory board has been excellent from start to finish. 

"The development of mAI Companion® should serve as a model for the future introduction of AI medical devices into interventional endoscopic practice.” — Prof. Dr. Lee Swanstroem, Interventional Endoscopist, Oregon Health and Science University, Portland Oregon USA and Director Emeritus, IHU-Strasbourg Institute of Image Guided Surgery, Strasbourg, France, told That's Health.

“When we started the research project at the IHU in Strasbourg seven years ago, it was a dream to develop a product that would help endosonographers to do a complete pancreatic evaluation. Now that dream has become reality. 

"I see mAI Companion as a great opportunity in medicine for more gastroenterologists to offer their patients high and consistent quality in the performance of pancreatic endoscopic ultrasound that will lead to a early diagnosis of pancreatic diseases and cancer, and I am convinced that this AI will help us doctors save patients' lives. mAI Companion will be my companion.” — Dr. Leonardo Sosa Valencia, Clinical Gastroenterologist, Digestive Echo Endoscopist, Medical Staff Manager at IHU, Strasbourg, France

"This is a major milestone for Medi-Globe. Turning mAI Companion® from concept to clinical reality required close collaboration with our partners at IHU Strasbourg and a broad international medical advisory network. Our goal is to provide clinicians with practical, workflow-integrated AI support that increases quality, confidence and consistency in pancreatic EUS." — Marc Jablonowski, Managing Director, Medi-Globe, Rohrdorf, Germany

"Delivering this programme on time and on budget reflects our disciplined approach from early prototype through MDR CE Mark, combining rigorous engineering, close clinical collaboration, and a strong focus on quality and compliance." — Dr. Markus Schönberger, President, iGlobe Scientific, Strasbourg, France

A New Era for Evidence-Based AI in Endoscopy

The launch of mAI Companion® represents a key milestone in Medi-Globe’s commitment to clinically validated, evidence-based AI solutions that can be safely integrated into routine practice, supporting earlier intervention and improved patient pathways.

With CE-marked approval, mAI Companion® is now cleared for clinical use across the EU, with initial deployments underway at leading European centres and broader rollout planned. For demonstrations or purchasing inquiries, contact Medi-Globe.

https://www.medi-globe.de/en/products/details/mai-companion

Monday, 23 February 2026

BIXOLON Introduces Healthcare-Optimised Desktop Printers with Advanced Safety and Hygiene Features to the European Market

BIXOLON Europe GmbH, a subsidiary of BIXOLON Co. Ltd, a leading global Mobile, Label and POS printer manufacturer, today announces the European launch of its NEW Healthcare desktop printer line, comprising of the XD5-40IId and XD5-40IIt Healthcare models.

Designed specifically to meet the stringent requirements of today’s healthcare environments, the range brings together BIXOLON’s proven desktop printing performance with enhanced features tailored for medical applications.

Launching as part of the XD5-40II series which comprises of the XD5-40IId direct thermal and XD5-40IIt thermal transfer label printers, alongside the XD5-40IItR RFID printer with UHF printing and encoding capabilities. 

These new 4-inch (118 mm) Healthcare models deliver 203 dpi high-resolution printing at speeds of up to 8 ips (203 mm/sec). Offering a full suite of connectivity options - including USB, USB Host, Serial, Ethernet, WLAN and Bluetooth which is supported by powerful processing for rapid data throughput. Featuring an integrated LCD display, compact footprint, simple maintenance and broad media compatibility, the XD5-40II Healthcare series provides dependable performance for busy clinical environments.

To meet the specific needs of European hospitals, laboratories and other healthcare facilities, the models have built with additional medical-grade enhancements. 

Each device is equipped with an IEC 60601-1 compliant power supply for safe operation in patient care areas, while the disinfectant-ready, antimicrobial casings are designed to withstand regular cleaning cycles and help reduce contamination. 

Their UV-resistant enclosures ensure long-term durability, even with repeated sterilisation or UV exposure. 

These combined features make the NEW healthcare models ideal for applications such as patient ID wristbands, specimen and diagnostic test labelling, pharmacy dispensing and healthcare asset tracking—supporting improved patient safety, regulatory compliance and overall operational efficiency.

“As healthcare providers across Europe continue to prioritise patient safety and operational resilience, our new Healthcare series offers a reliable, compliant and future-ready solution,” Paul Kim, Managing Director, BIXOLON Europe GmbH, told That's Health.

“The XD5-40II H range are purposely-built to support the unique standards and expectations of European clinical environments.”

www.BixolonEU.com

Helping Older People Stay Safe and Independent at Home

Age Concern Hampshire’s Help at Home Service continues to provide vital practical support and companionship to older people across the county, helping them stay safe, independent, and connected in their own homes. 

By assisting with everyday household tasks such as cleaning, shopping, meal preparation, and light domestic chores, the service helps reduce the risks that can arise when these activities become more physically demanding.

As people get older, routine chores like bending to clean, carrying shopping bags, reaching high shelves, or moving around cluttered spaces can significantly increase the risk of slips, trips, and falls.

 Research shows that one in three people aged 65 and over experiences a fall each year, rising to almost half of people aged 80 and over. Many of these falls happen in the home while carrying out everyday tasks and are a leading cause of injury, hospital admission, and loss of independence among older people.

Without support, older people may feel pressure to push themselves to complete chores they are no longer physically comfortable doing, increasing fatigue, isolation, and the likelihood of accidents. 

Regular visits from a trusted helper not only ensure tasks are completed safely but also provide companionship, reassurance, and social connection, which are essential for maintaining confidence and wellbeing.

“Even simple tasks like shopping, cleaning, or preparing meals can increase the risk of falls as people get older,” Hannah Park, Head of Operations told That's Health.

“Our Help at Home Service provides reliable practical support alongside friendly companionship, helping people feel safe, confident, and supported in their own homes.”

Age Concern Hampshire operates the Help at Home Service across the county, arranging visits to suit individual needs. To find out more visit: https://www.ageconcernhampshire.org.uk/our-services-hampshire/help-at-home or call 01962 868545.

Sunday, 22 February 2026

Rare Disease Day: Why Awareness Matters More Than Ever

Every year on 28 February (or 29 February in leap years), the world marks Rare Disease Day, a global campaign dedicated to raising awareness of conditions that individually affect small numbers of people, but collectively impact millions worldwide.

In the UK alone, it's estimated around 3.5 million people live with a rare disease. Globally, that figure rises to overmore than 300 million. 

Despite the numbers, many patients still face delayed diagnosis, limited treatment options and ongoing misunderstanding.

For That’s Health, this day is about shining a light on stories that are too often overlooked.

What Is a Rare Disease?

A disease is considered rare in the UK if it affects fewer than 1 in 2,000 people. However, there are more than 7,000 known rare conditions. 

Around 72% are genetic, and many begin in childhood, though others emerge later in life.

Examples include:

Huntington's disease

https://www.hda.org.uk/information-and-support/huntingtons-disease/what-is-huntingtons-disease

Cystic fibrosis

https://www.cysticfibrosis.org.uk

Ehlers-Danlos syndrome

https://www.ehlers-danlos.com/what-is-eds

Duchenne muscular dystrophy

https://www.duchenneuk.org/what-is-duchenne

Some are life-limiting. Others are chronic and complex, affecting multiple body systems and requiring specialist care.

The Challenge of Diagnosis

One of the biggest hurdles facing people with rare diseases is simply getting a diagnosis.

It can take years, sometimes decades, for patients to receive clarity. Symptoms may be misattributed, dismissed, or misunderstood. Families often describe a long and exhausting search for answers, moving from specialist to specialist.

Earlier diagnosis matters. It can:

Improve treatment outcomes

Allow families to plan and access support

Connect patients with specialist communities

Reduce mental health strain caused by uncertainty

Living With a Rare Condition

Rare diseases do not just affect physical health. They impact education, employment, finances and relationships.

People may feel isolated, especially if there are very few others locally with the same condition. Support groups, online communities and charities play a vital role in providing connection and practical advice.

In the UK, organisations such as Genetic Alliance UK and Rare Disease UK campaign for improved services, research funding and better policy support.

https://geneticalliance.org.uk

https://rd-research.org.uk

Why Awareness Still Matters

Awareness days are sometimes criticised as symbolic gestures. But for rare disease patients, visibility can lead to real change.

Awareness can:

Encourage earlier referrals and recognition by healthcare professionals

Support funding for research and innovative therapies

Influence government health strategies

Reduce stigma and misunderstanding

The UK has developed rare disease frameworks to improve coordination of care, but continued momentum is essential.

Research and Hope

Scientific advances, particularly in genetics and personalised medicine, are transforming the landscape of rare disease treatment. Gene therapies, targeted biologics and improved diagnostic tools are offering new hope.

However, research into rare diseases often receives less funding due to smaller patient populations. Advocacy remains crucial to ensure progress continues.

How You Can Support Rare Disease Day

You do not need to be directly affected to make a difference. You can:

Share information on social media

Support rare disease charities

Learn about conditions affecting people in your community

Encourage compassionate conversations

Even a small action can reduce isolation for someone living with a rare diagnosis.

Rare diseases may be individually uncommon, but collectively they represent a significant public health issue. Behind every statistic is a person navigating uncertainty, resilience and strength.

Rare Disease Day reminds us that awareness is not just about facts and figures, it is about empathy, research, and ensuring that no one feels invisible.

For more health awareness features and UK-focused wellbeing content, keep following That’s Health.

Friday, 20 February 2026

Rebuilding After “Superflu”: Restoring Stamina, Strength and Well-Being

A tough bout of flu, or something more serious such as some strains of COVID-19, can leave you feeling drained long after the fever fades. 

Fatigue, weakness and breathlessness are common. The key to recovery is gradual progress, good nutrition and sensible exercise.

Start Slowly

Before structured workouts, begin with:

Gentle stretching

Short walks around the house

Light mobility work

Slow, steady breathing exercises

If symptoms worsen the next day, ease back. Recovery should feel progressive, not punishing.

Using a Home Treadmill Wisely

A treadmill offers controlled, weather-proof exercise, ideal for rebuilding stamina steadily.

Weeks 1–2

5–15 minutes walking

Flat incline

Comfortable, conversational pace

Weeks 3–4 (if symptom-free)

Extend to 20 minutes

Add short brisk intervals

Avoid rushing into running

Monitor breathlessness and next-day fatigue. Consistency matters more than intensity.

Rebuild Basic Strength

Illness reduces muscle mass quickly. Start small:

Bodyweight squats

Wall push-ups

Resistance band exercises

Two short sessions weekly is enough at first. Rest between sessions.

Nutrition for Recovery

Focus on:

Protein (eggs, fish, beans)

Wholegrains for energy

Healthy fats such as olive oil

Hydration

Small, regular meals can help if appetite is low.

Supplements: Keep It Sensible

Some people consider:

Vitamin D (especially in the UK winter)

Vitamin C and zinc

Magnesium

Omega-3

Avoid high doses and check with a GP or pharmacist if unsure.

Don’t Neglect Sleep

Quality sleep supports immune repair and muscle recovery. Keep a regular bedtime and limit late-night screen use.

When to Seek Advice

Consult a professional if you experience:

Ongoing chest pain

Severe breathlessness

Heart palpitations

Extreme fatigue lasting months

Final Thoughts

Recovery from “superflu” isn’t about pushing hard, it’s about rebuilding steadily. Gentle treadmill walking, basic strength work, balanced meals and sensible supplementation can help you regain stamina safely.

Progress may be gradual, but it will come.

New Age UK East Sussex charity shop opens in the heart of Eastbourne

Age UK East Sussex has officially opened a new charity shop in Langney Road, providing a welcoming new space for the community to shop, donate and support older people across the county.

Located in Langney Road, the new shop offers a wide range of quality clothing, books, household goods and other pre-loved items, all raising vital funds to support the charity’s work with older people in East Sussex.

The opening was marked by a visit from the The Worshipful the Mayor of Eastbourne, Councillor Margaret Bannister, alongside representatives from Age UK East Sussex, volunteers and members of the local community.

“It’s wonderful to be here to help celebrate the opening of Age UK East Sussex’s new shop. This is a positive step for the charity and for the many older people across our community who will benefit from its work.”

Supporting older people across East Sussex

Age UK East Sussex is a local, independent charity that has been supporting older people in the community for over 75 years. With a dedicated team of staff and volunteers, the charity delivers services, activities and advice that make a real difference to people in later life.

The charity supports thousands of older people each year, helping to reduce loneliness, improve wellbeing and enable people to live independently for as long as possible.

A shop with a purpose

The new Eastbourne shop is one of five charity shops and two furniture stores across the county that are run by Age UK East Sussex. As well as offering great value items, the shop plays an important role in funding the charity’s frontline services and creating opportunities for volunteering in the local area.

“I was so happy when I saw that this new shop was looking for volunteers. I applied straight away as I’ve been out of work for a while and wanted to build my confidence again,” said one new volunteer. “So far it has been everything I hoped it would be. The team are lovely and the customers are friendly. It’s done so much for me already.”

Get involved – Volunteer with them!

Age UK East Sussex is inviting local people to get involved by volunteering at the new Eastbourne shop.

There are a variety of roles available to suit different interests and availability - from welcoming customers and serving on the shop floor, to sorting donations and preparing stock behind the scenes. 

Whether someone can spare a few hours a week or more regular time, there is something for everyone.

Volunteering with Age UK East Sussex is a great way to meet new people, learn new skills and be part of a friendly team - all while helping to raise vital funds to support older people across East Sussex.

Anyone interested in volunteering can speak to the team in store, call 01273 476704, or email volunteers@ageukeastsussex.org.uk to find out more.

https://www.ageuk.org.uk/eastsussex

GrĂ¼nenthal’s proprietary NaV 1.8 inhibitor enters clinical development

GrĂ¼nenthal has announced that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. 

The orally administered investigational medicine aims to provide a non-opioid therapy option across a range of acute and chronic pain conditions. Full results of the trial are expected in the second half of this year, 2026.

The Phase I trial will involve 70 healthy volunteers and comprises a Single Ascending Dose and a Multiple Ascending Dose part. It aims to assess the safety and tolerability profile and the pharmacokinetic characteristics of the investigational medicine. In addition, the trial will generate initial insights into the compound’s pharmacology through a cold-pressor test.

“Inhibition of NaV 1.8 offers an exciting opportunity to provide patients with urgently needed non-opioid pain therapies,” Uli Brödl, Chief Scientific Officer, GrĂ¼nenthal, told That's Health.

 “While we have seen the first medicine targeting NaV 1.8 receive FDA approval last year, we are committed to driving further innovation in this field where advanced assets may provide enhanced patient outcomes by blocking NaV 1.8 more comprehensively.”

About voltage-gated sodium channels (NaV)

There are a total of nine different NaV channels in the human body. The NaV 1.8 channel is a clinically and genetically validated pain target, as the channel plays a significant role in triggering excitatory signals in nociceptive neurons, which the human brain perceives as pain. Blocking the NaV 1.8 channel to suppress or prevent its excitatory signalling will provide a significant analgesic effect across a range of chronic and acute pain conditions.

FACTFILE:

GrĂ¼nenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, they have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Their purpose is to change lives for the better – and innovation is their passion. They focus all  their activities and efforts on working towards our vision of a World Free of Pain.

GrĂ¼nenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America, and the U.S. 

Their products are available in approx. 100 countries. In 2024, GrĂ¼nenthal employed around 4,300 people and achieved revenues of €1.8 billion.

For more information visit: https://www.grunenthal.com.

UK Men’s Sheds Association launches new guide to help communities set up Men’s Sheds in shipping containers

The UK Men’s Sheds Association (UKMSA) has launched a free practical guide to help communities across the UK establish Men’s Sheds using shipping containers - a flexible, affordable and increasingly popular solution for creating safe workshop and social spaces for men.

Men’s Sheds play a vital role in tackling loneliness and social isolation, particularly among older men and those experiencing life changes such as retirement, bereavement or poor health. 

By providing shared spaces where men can connect, learn skills and support one another, Sheds contribute positively to mental health, suicide prevention, alcohol moderation and community wellbeing.

With community premises hard to come by in many areas of the UK, the new publication, Shipping Container Set Up for Sheds, draws on real-world experience from Men’s Sheds currently operating in containers, including detailed case studies from Amersham and Wendover Men’s Sheds. 

As of December 2025, at least 27 Men’s Sheds across the UK are using shipping containers as their main workshop space.

“The container didn’t just solve our space issue - it gave our members a meaningful project. Refitting it ourselves created purpose, teamwork and real pride. The finished workshop represents not just a building, but the confidence and skills gained along the way,” John Latchford of Amersham Men’s Shed in Buckinghamshire, told That's Health.

Shipping containers offer a quick and cost-effective way for new and developing Sheds to get started, particularly where permanent buildings are not viable. They are secure, weather-resistant, portable, and can be adapted for workshops, social spaces, storage and off-grid use.

The guide covers every stage of the process, including:

Planning, access and foundations

Power, lighting and ventilation

Health and safety, insurance and regulatory considerations

Workshop layout and future expansion

Insulation, noise control and dust management

Real case studies and practical lessons learned

The guide also highlights how container-based Sheds can grow over time, with examples of modular expansion, outdoor covered workspaces and renewable energy solutions.

By sharing practical advice and honest insights from experienced Sheds, UKMSA aims to reduce barriers for communities looking to create welcoming spaces that support men’s health, wellbeing and social connection.

“Shipping containers have enabled many Sheds to get up and running quickly and safely, often in places where no other option existed,” Rachel Meadows, head of development at UKMSA, added. 

“This guide brings together the collective knowledge of Shedders who’ve already done it, helping others avoid common pitfalls and make informed decisions.”

The Shipping Container Set Up for Sheds guide is aimed at community groups, local authorities, funders and anyone interested in developing a Men’s Shed. It is available now at https://menssheds.org.uk/mens-sheds-resources/

For more information on starting up a Men’s Shed visit https://menssheds.org.uk/start-a-shed/

Extraordinary Conceptions Announces US/UK Hybrid Surrogacy Programme

Extraordinary Conceptions, a global leader in surrogacy and egg donation with over two decades of experience, today announced the continued expansion of its U.S./UK Hybrid Surrogacy Programme, an international model that has successfully supported UK families for over five years.

Developed in response to long surrogate matching delays in the UK due to somewhat outdated surrogacy legislation, the Hybrid Programme enables intended parents to create embryos locally with their trusted UK fertility specialists, while moving their journey forward quickly through matching with thoroughly vetted U.S.-based surrogates. 

This approach provides families with access to enforceable legal contracts, pre-birth orders, and comprehensive medical and insurance protections available in the United States.

Through this established model, Extraordinary Conceptions has already supported numerous successful international surrogacy journeys, offering UK families a reliable, secure, and efficient alternative to domestic-only programs.

How the Hybrid Model Works

The program is structured around a seamless two-country journey, combining the best of both healthcare systems:

• IVF & Embryo Creation in the UK

Intended parents complete fertility treatment and embryo creation with their chosen UK specialists, maintaining continuity of care with physicians they know and trust.

• Surrogate Travel for Embryo Transfer

Once embryos are created, Extraordinary Conceptions matches families with a qualified U.S. surrogate—often within a significantly shorter timeframe than in the UK. The surrogate travels to the UK for the embryo transfer, which is managed under the guidance of the intended parents’ IVF clinic. Following the procedure, the surrogate returns to her home state to continue the pregnancy.

• U.S.-Managed Pregnancy & Delivery

The pregnancy, legal process, insurance coverage, and delivery are managed in the United States, including the establishment of parental rights through pre-birth orders and coordinated care at leading hospitals and fertility clinics.

• End-to-End Agency Support

Extraordinary Conceptions works closely with UK fertility clinics to coordinate every aspect of the journey—from matching and legal services to travel logistics, case management, and emotional support—ensuring a seamless experience.

“Our mission has always been to make surrogacy accessible, ethical, and transparent for families around the world. The Hybrid Program was built with UK families in mind — so they never have to choose between the doctors they trust and the legal security they deserve. Parents can have both," Hilary Smith, Head of International Development, Extraordinary Conceptions, told That's Health.

Transparent, Competitive Pricing

The Hybrid Surrogacy Programme is offered at an estimated total cost of USD $130,000 to $150,000, depending on individual medical circumstances. This comprehensive fee typically covers:

Full agency coordination, from initial consultation through surrogate matching

Surrogate compensation, wellness support, and living expense allowance

U.S.-based legal services, including surrogacy agreements and parental rights establishment

Surrogate medical insurance for the duration of the pregnancy

Round-trip travel and accommodation for the surrogate's UK embryo transfer

As demand for international fertility solutions continues to rise, the Hybrid Program represents a new benchmark for safe, ethical, and family-centered surrogacy care.

www.extraconceptions.com

Tuesday, 17 February 2026

Know GvHD marks GvHD Day on February 17, 2026, with “Together through GvHD” campaign

Image courtesy gvhdhub.com

Know GvHD will mark GvHD Day on Tuesday February 17, 2026, uniting patients, caregivers, ambassadors, societies, and the wider community to raise awareness of graft-versus-host disease (GvHD) and the long-term impact it can have on those affected.

GvHD Day aims to shine a light on the ongoing physical and psychological effects of GvHD and its treatment, as well as the continuing need for education, support, and connection. 

Many people remain unaware of the long-term biological, physical, and emotional challenges associated with GvHD, the supportive care options available, and where patients, caregivers, and families can find trusted information and practical guidance. GvHD Day 2026 seeks to address these gaps by making easily-accessible, patient-focused resources available to the entire GvHD community.

Together through GvHD

This year’s campaign – Together through GvHD – is rooted in connection, understanding, and hope. It is a reminder to every patient and caregiver affected by GvHD that they are not alone and that support, information, and community are within reach.

Connect. Share. Feel supported.

As part of the campaign, Know GvHD is bringing together a range of supportive resources and peer networks for people affected by GvHD. This includes a new Support Groups section on the website, featuring links to trusted organizations and communities where patients and caregivers can find help, connection, and shared experiences.

The campaign also includes a dedicated WhatsApp support group, hosted by Know GvHD patient ambassadors. This supportive and welcoming space allows people living with GvHD to connect with others who understand, share experiences, ask questions, and find reassurance from peers navigating similar challenges.

Be part of GvHD Day

To help drive awareness and visibility on February 17, Know GvHD is inviting supporters to take part in a simple but meaningful activity:

Download a Know GvHD poster from the website or order printed copies

Take a photo with the poster

Share the photo on social media and tag Know GvHD

This collective action reflects the spirit of Together through GvHD, highlighting the importance of connection, visibility, and community for everyone affected by GvHD.

Helping patients at every step of their journey

Know GvHD is also introducing Know GvHD business cards, designed to raise awareness of the website as a trusted hub where patients and caregivers can:

Access clear, reliable education

Connect with others who understand GvHD

Find ongoing support and reassurance

Posters and business cards will be distributed across blood and marrow transplantation centers, hospitals, and relevant societies, helping ensure that patients encounter Know GvHD at key moments in their journey. Information on how to order business cards is available on the website here: https://know-gvhd.com/gvhd-day/

Help spread the word

Please share and disseminate Know GvHD resources, including:

Patient stories

Patient interviews

WhatsApp invite link

Downloadable poster and business cards

Know GvHD website link

When sharing on social media, please use these official hashtags:

#GvHDDay #GVHDAlliance #GvHDConnect4Hope

Together, the community can raise awareness, strengthen connections, and help build a more supportive future for everyone affected by GvHD.

Together through GvHD, because no one should face GvHD alone.

For more information on GvHD Day, please visit:

https://know-gvhd.com/gvhd-day

https://scientificeducationsupport.com

https://gvhdhub.com

Improved Pregnancy Outcomes for Women With Thyroid Conditions? BTF Has it Wrapped!

The Wrapped Brand Agency has been appointed by the British Thyroid Foundation (BTF) to develop a new nationwide awareness and education campaign aimed at improving conception and pregnancy outcomes for women who are affected by thyroid conditions.

The partnership will focus on translating new UK clinical guidance into clear, accessible resources for women and healthcare professionals, helping ensure thyroid conditions are identified and managed effectively before, during and after pregnancy.

Thyroid conditions affect around one in 20 people in the UK and disproportionately impact women. Poorly managed thyroid levels can make it harder to conceive and increase the risk of miscarriage and complications during pregnancy. 

Yet many women struggle to access clear, trusted information at a time when reassurance and practical guidance matter most.

Working closely with the BTF and women with lived experience, Wrapped will help develop patient-friendly resources and bite-sized educational content designed to build confidence, reduce anxiety and encourage early action, including speaking with a doctor, monitoring thyroid levels and following appropriate treatment plans. The campaign will also support GPs and midwives with simple, credible materials to help them confidently signpost patients and deliver guideline-led care.

The work aligns with newly published national clinical guidance from the Royal College of Obstetricians and Gynaecologists on managing thyroid disorders in pregnancy, creating an opportunity to reach women earlier and improve outcomes for both mothers and babies.

Mark Robinson, Chief Commercial Officer at Wrapped, told That's Health: “This project is about turning complex clinical guidance into something human, reassuring and genuinely useful. 

"Too many women are left feeling anxious, confused or unsupported when managing thyroid health alongside pregnancy. 

"We believe our role is to help bridge that gap, creating clear, accessible resources that empower women to take control of their thyroid health and support healthcare professionals to have confident, informed conversations.

“This partnership is also very personal for us at Wrapped. My daughter lives with an underactive thyroid, so we understand first-hand how important timely information and support can be. 

"We’re proud to be working alongside the BTF to help more women feel informed, supported and hopeful at such a critical time in their lives.”

Anna Woollven, Communications and Fundraising Manager at the British Thyroid Foundation, told us: “Every week we hear from women who have experienced difficulties conceiving or during pregnancy because their thyroid condition wasn’t managed as well as it could have been. Many tell us they struggled to find clear, trustworthy information when they needed it most.

“By working with Wrapped, we’re creating resources that reflect real patient needs and make it easier for women to understand what steps to take, while also helping healthcare professionals share consistent, evidence-based guidance. Our goal is simple: to help women access the right care at the right time, feel more in control of their condition, and improve pregnancy outcomes across the UK.”

The campaign will combine patient insight, clinical evidence and lived experience to deliver a joined-up programme of digital and printed resources, supported by targeted awareness activity. It aims to increase understanding of thyroid health in pregnancy, encourage earlier conversations with healthcare professionals and reduce the risk of avoidable complications through better monitoring and management.

https://www.btf-thyroid.org

https://wrappedagency.co.uk

Monday, 16 February 2026

Boots health and beauty bargain box opening


My wife and I have the Boots app on our phones and we received a notification of a bargain flash sale of a beauty box.

We bought one each and these are the contents of the boxes.

You can learn about Boots flash sales and the Boots app at www.boots.com.

Saturday, 14 February 2026

Singles Awareness Day: Celebrating Independence, Self-Worth and Living Life Your Way

While the world is awash with roses, heart-shaped chocolates and candlelit dinners in mid-February, 15th February quietly marks something a little different: Singles Awareness Day.

Far from being a gloomy afterthought to Valentine’s Day, it has grown into a celebration of independence, friendship, resilience and self-love. Whether you are single by choice, circumstance, or simply focusing on other priorities, this day offers a chance to reframe the narrative.

What Is Singles Awareness Day?

Singles Awareness Day (often shortened to SAD — though thankfully in an ironic way!) takes place on 15th February. Originally seen as a tongue-in-cheek response to Valentine’s Day, it has evolved into a positive celebration of:

Personal growth

Independence

Friendship

Self-care

Freedom from social pressure

It’s not about being anti-relationship. It’s about recognising that being single is not a “waiting room” for life.

Why It Matters

Society can sometimes place heavy emphasis on romantic partnership as a marker of success or fulfilment. From films to advertising campaigns, the message can be subtle but persistent: happiness equals coupledom.

But in reality, single life can offer:

Greater flexibility and autonomy

More time to invest in career or creative pursuits

Stronger friendships and community ties

Financial independence

Personal development opportunities

Being single is not a gap in your story — it is part of your story.

Healthy Ways to Celebrate Singles Awareness Day

1. Invest in Yourself

Book that course. Start that fitness goal. Launch that side project. Use the day as a personal reset button.

2. Celebrate Friendship

Gather friends for dinner, a film night or even a pub quiz. Platonic love deserves just as much celebration.

3. Practice Intentional Self-Care

This might mean:

A long countryside walk

A favourite takeaway

Switching off social media for the day

Finally reading that book on your bedside table

4. Reflect on What You Truly Want

Singles Awareness Day can be a useful moment to assess your values. If you do want a relationship, what does a healthy one look like for you? If you are content as you are, what makes that fulfilling?

There is power in clarity.

Reframing the Narrative

Instead of viewing singlehood as “alone”, try reframing it as:

Self-directed

Unrestricted

Independent

Whole

Your value is not defined by your relationship status. Confidence grows when your sense of identity comes from within rather than external validation.

The Business and Cultural Shift

Interestingly, retailers and hospitality venues are increasingly recognising that not everyone is celebrating Valentine’s Day as a couple. Promotions aimed at “treat yourself” experiences, solo travel packages, and friendship-focused events have become more common.

It reflects a broader cultural understanding: modern life is diverse, and so are relationships.

A Final Single Thought

Whether you are happily single, newly single, or somewhere in between, Singles Awareness Day is an invitation to celebrate yourself — not in defiance of romance, but in recognition of your inherent worth.

Love is important. But so is self-respect, independence and joy in your own company.

And those are worth celebrating every day of the year.